A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on Inflammation
Non-clinical
Cardiovascular Toxicity
In Vitro
Shields (2017)
E-Cigarette aerosol Condensate Leads to Impaired Coronary Endothelial Cell health and Restricted angiogenesis.
Nonclinical
Cardiovascular Toxicity
In Vitro
Chhor (2023)
Effects of Electronic Cigarette Exposure on Myocardial Infarction and No-Reflow, and Cardiac Function in a Rat Model.
Nonclinical
Cardiovascular Toxicity
In Vitro
Dai (2023)
E-cigarette effects on vascular function in animals and humans.
Nonclinical
Cardiovascular Toxicity
In Vitro
Daiber (2023)
addressing the challenges of E-cigarette safety profiling by assessment of pulmonary toxicological response in bronchial and alveolar mucosa models.
Nonclinical
Cardiovascular Toxicity
In Vitro
Ganguly (2020)
Impact of cigarette versus electronic cigarette aerosol conditioned media on aortic endothelial cells in a microfluidic cardiovascular model.
Nonclinical
Cardiovascular Toxicity
In Vitro
Makwana (2021)
In Vitro Biological Effects of E-Cigarette on the Cardiovascular System-Pro-Inflammatory Response Enhanced by the Presence of the Cinnamon Flavor.
Nonclinical
Cardiovascular Toxicity
In Vitro
Michon (2022)
Systems toxicology-based assessment of the candidate modified risk tobacco product ThS2.2 for the adhesion of monocytic cells to human coronary arterial endothelial cells
Non-Clinical
Cardiovascular Toxicity
In Vitro
Poussin (2016)
Use of human Induced Pluripotent Stem Cell-Derived Cardiomyocytes to Predict the Cardiotoxicity Potential of Next Generation Nicotine Products.
Nonclinical
Cardiovascular Toxicity
In Vitro
Simms (2022)